Target Discovery, Inc. Company Profile

07:45 EDT 20th June 2018 | BioPortfolio

Target Discovery discovers, validates, and utilizes protein isoforms to improve clinical diagnosis and management of disease. A growing body of scientific literature shows that protein isoforms correlate more precisely with disease state and patient-specific treatment response than current clinical biomarkers. Most protein isoforms (90%) are made by the body after the protein is produced (post-translational modifications). Such protein modifications remain largely inaccessible to current immunodiagnostic and nucleic acid clinical assays. Target Discovery's Isonostic™ products are designed to make this isoform biomarker information accessible to clinicians.


4030 Fabian Way
Palo Alto
United States of America


Phone: 1.650.812.8100
Fax: 1.650.812.8130

News Articles [615 Associated News Articles listed on BioPortfolio]

Most downloaded review Q1 2009: Target discovery from data mining approaches

The most downloaded review article from Drug Discovery Today from the first quarter of 2009 deals with the topic of target discovery from the informatics perspective. It would be difficult to overstat...

A matter of mobility: New strategy for drug discovery

A joint industry/academia study of a cancer target protein reveals unusual relation between binding site flexibility and drug-target lifetime. The results suggest a new strategy for drug discovery.

CHI’s Discovery on Target, Sheraton Boston, Sept. 25-28, 2018

CHI’s Discovery on Target, Sheraton Boston, Sept. 25-28, 2018 Reporter: Aviva Lev-Ari, PhD, RN   ANNOUNCEMENT Leaders in Pharmaceutical Business Intelligence (LPBI) Group is a selected CHI ...

InterMed Discovery: The World's Largest Natural Product Library

In this interview Fintan Walton talks to Mr Erik Metz, Head of Business Development at InterMed Discovery - a Natural Product lead discovery company from Dortmund, Germany. Erik Metz explains how Inte...

Discovery of Novel Malaria Parasite Behaviour Offers New Target for Treatment

Researchers have demonstrated novel parasite behaviour which offers a potential new target for malaria diagnosis and intervention. Malaria, a blood borne disease caused by single cell parasites, remai...

Incyte and Syros Enter Global Target Discovery and Validation Collaboration Focused on Myeloproliferative Neoplasms

WILMINGTON, Del. & CAMBRIDGE, Mass.–(BUSINESS WIRE)–Incyte Corporation (NASDAQ:INCY) and Syros Pharmaceuticals, Inc. (NASDAQ:SYRS) announced today that the companies have entered into ...

A new molecular target identified in depression

The discovery of a new mechanism involved in depression -- and a way to target it with a drug as effective as classical antidepressants -- provides new understanding of this illness and could pave the...

C4X Discovery acquires Adorial Pharma

Manchester-headquartered drug researcher C4X Discovery has acquired the developer of a mathematical tool that identifies the causes of disease that can be targeted by pharmaceuticals. C4X has bought ...

PubMed Articles [1422 Associated PubMed Articles listed on BioPortfolio]

Early Probe and Drug Discovery in Academia: A Minireview.

Drug discovery encompasses processes ranging from target selection and validation to the selection of a development candidate. While comprehensive drug discovery work flows are implemented predominant...

Quantitative Prioritization of Tool Compounds for Phenotypic Screening.

Phenotypic screens are increasingly utilized in drug discovery for multiple purposes such as lead and/or tool compound finding, and target discovery. Using potent and selective chemical tool compounds...

Pathway-based technologies for early drug discovery.

Although the traditional drug discovery approach has led to the development of many successful drugs, the attrition rates remain high. Recent advances in systems-oriented approaches (systems-biology a...

Single-Cell Droplet Microfluidic Screening for Antibodies Specifically Binding to Target Cells.

Monoclonal antibodies are a main player in modern drug discovery. Many antibody screening formats exist, each with specific advantages and limitations. Nonetheless, it remains challenging to screen an...

Molecular insights into trypanothione reductase-inhibitor interaction: A structure-based review.

Information on how small molecules bind to the target enzyme has the potential to impact immensely on how medicinal chemists go about antiparasitic drug discovery. In this review, for the first time, ...

Clinical Trials [1749 Associated Clinical Trials listed on BioPortfolio]

Discovery Elbow Multi-Center Prospective Study

The purpose of this prospective clinical trial is to document the performance and clinical outcomes of Biomet Discovery Elbow.

A Clinical Investigation of the Discovery™ Elbow System

The purpose of this study is to perform a five-year, multi-center prospective evaluation of the Discovery™ Elbow System for outcome and durability. Relief of pain and restoration of fun...

Efficacy and Safety of Imatinib in Scleroderma

In vitro studies have shown that imatinib 1mM inhibits strongly the growth of cutaneous fibroblasts. The hypothesis is that imatinib inhibits PDGFR which is known to be a potential target ...

Evaluate the Analgesic Efficacy and Safety of VVZ-149 Injection for Post-operative Pain

VVZ-149 is a novel analgesic drug candidate that shows a potential analgesic activity inhibiting GlyT2 and 5HT2A simultaneously. These target receptors have been known to play important ro...

Road to Discovery for Combination Probiotic BB-12 With LGG in Treating Autism Spectrum Disorder

This study will evaluate the safety and tolerability of BB-12 with LGG in healthy children with autism spectrum disorder aged 6-13 years. Subjects will be randomized to BB-12 with LGG oral...

Companies [1626 Associated Companies listed on BioPortfolio]

Chemocept, Inc.

Chemocept is a service company offering the biotechnology industry discovery chemistry support capabilities for use in biomolecular target validation and small molecule drug discovery. We facilitate ...

Target Discovery, Inc.

Target Discovery discovers, validates, and utilizes protein isoforms to improve clinical diagnosis and management of disease. A growing body of scientific literature shows that protein isoforms correl...

Crystax Pharmaceuticals S.L.

Crystax Pharmaceuticals is a leading structure-based drug discovery company providing a unique service to its partners. Crystax has developed an integrated discovery platform, from the identification ...

Target ALS Foundation

Target ALS is an independent, non-profit, and privately funded consortium of researchers from academic and biotech/pharma laboratories entirely focused on finding a treatment for ...

Vividion Therapeutics, Inc.

Conventional drug discovery is target-centric; a compound library is screened using a target-specific assay and high-affinity binding ligands are optimized to develop a drug candi...

More Information about "Target Discovery, Inc." on BioPortfolio

We have published hundreds of Target Discovery, Inc. news stories on BioPortfolio along with dozens of Target Discovery, Inc. Clinical Trials and PubMed Articles about Target Discovery, Inc. for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Target Discovery, Inc. Companies in our database. You can also find out about relevant Target Discovery, Inc. Drugs and Medications on this site too.

Quick Search


Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Within medicine, nutrition (the study of food and the effect of its components on the body) has many different roles. Appropriate nutrition can help prevent certain diseases, or treat others. In critically ill patients, artificial feeding by tubes need t...

Corporate Database Quicklinks

Searches Linking to this Company Record